Letter to the Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”

ElsevierVolume 26, Issue 12, December 2020, Pages e333-e334Biology of Blood and Marrow TransplantationAuthor links open overlay panelJie Zhang 1, Junlong Li 2, Qiufei Ma 2, Hongbo Yang 2, James Signorovitch 2, Eric Wu 2Show morePrevious article in issueNext article in issue

Recommended articles

Financial disclosure: See Acknowledgments on page e334.

© 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.

View original article
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comments (0)

No login
gif
format_indent_decrease